Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBSA0103 vs Synvisc for knee osteoarthritis
CTR20191170Phase 3Completed
- Sponsor
- LG Chem
- Start
- Jun 2019
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Synovian in knee osteoarthritis (OA), sponsored by LG Chem. Started Jun 2019; status: completed.
02
Drugs
Synovian
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20191170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191170.